[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_3294 

# __Protease inhibitors__

## Category to which it belongs

* [Creating a resilient and adaptable environment through technology, cooperation, contact tracing, natural elements, and proper measures.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_119.md)

## Closest similar item

* [Identification of potential therapeutic targets](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1954.md)
* [Antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3293.md)
* [Antiviral drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_236.md)
* [Antivirals](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_827.md)
* [Medications](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3260.md)
* [Anti-malaria drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_237.md)
* [Anti-inflammatory drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_238.md)
* [Antimalarial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3292.md)
* [Anti-bacterial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3291.md)
* [Clinical trials](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1959.md)

## This Technology enables the following mitigations

* [Use of specific medicines](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_4470.md)

